Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy

J Neuroimmunol. 2011 Apr;233(1-2):46-53. doi: 10.1016/j.jneuroim.2010.11.013. Epub 2010 Dec 24.

Abstract

JCV causes the CNS demyelinating disease progressive multifocal leukoencephalopathy (PML). After primary infection, JCV persists in a latent state, where viral protein expression and replication are not detectable. NF-κB and C/EBPβ regulate the JCV promoter via a control element, κB, suggesting proinflammatory cytokines may reactivate JCV to cause PML, e.g., in HIV-1/AIDS. Since HIV-1 induces cytokines in brain, including TNF-α, we examined a role for TNF-α in JCV regulation. TNF-α stimulated both early and late JCV transcription. Further, the κB element conferred TNF-α response to a heterologous promoter. Immunohistochemistry of HIV+/PML revealed robust labeling for TNF-α and TNFR-1. These data suggest TNF-α stimulation of κB may contribute to JCV reactivation in HIV+/PML.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications
  • Acquired Immunodeficiency Syndrome / immunology
  • Cell Line
  • HIV-1 / immunology
  • Humans
  • Immunocompromised Host
  • JC Virus / genetics
  • JC Virus / immunology*
  • Leukoencephalopathy, Progressive Multifocal / immunology*
  • Leukoencephalopathy, Progressive Multifocal / metabolism
  • Leukoencephalopathy, Progressive Multifocal / virology*
  • Promoter Regions, Genetic / genetics
  • Promoter Regions, Genetic / immunology
  • Receptors, Tumor Necrosis Factor, Type I / metabolism
  • Transcriptional Activation / immunology
  • Tumor Necrosis Factor-alpha / physiology*
  • Virus Activation / genetics
  • Virus Activation / immunology*

Substances

  • Receptors, Tumor Necrosis Factor, Type I
  • Tumor Necrosis Factor-alpha